DAVID VESCO: Open Payments
NPI 1629084074 · CALABASAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,106 in 47 payments from 6 companies in 2025. Trend: 2023 $1,079 · 2024 $1,107 · 2025 $1,106
Food & beverage: $1,106
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 36 | $838 |
| AstraZeneca Pharmaceuticals LP | 7 | $171 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| Lilly USA, LLC | 1 | $25 |
| PFIZER INC. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
Products named: OTEZLA, REPATHA, BREZTRI, AIRSUPRA, JARDIANCE, MOUNJARO, PAXLOVID, LEQVIO.
Industry payments across CA — which companies pay providers there.
